12.15.25 -- 2025 GLP-1 Impacts Tell Us About CDMOs In 2026

Here, adrulipase spray-dried dispersions were evaluated to create an orally delivered, enteric-protected enzyme. The lead formulation provided the best acid protection, rapid release, and stability.

Discover how to effectively navigate the transition to GMP, ensuring your project meets stringent requirements while streamlining development and minimizing risk.

Early planning for scale-up and biologics license application activities can maximize your chances of success by allowing sufficient time to develop launch options and prevent costly delays and setbacks.

The EMA has now issued a draft guidance on quality aspects of phage therapy medicinal products. Rising antimicrobial resistance has renewed interest in bacteriophages to fight pathogens.

Optimize your validation strategy to meet evolving regulatory demands and product complexities with a scalable, efficient framework that accelerates facility readiness and ensures consistent quality.

Uncover how this solid-state HDX-MS is being used to revolutionize the prediction of stability for IgG-based Antibody Drug Conjugates and enhance ADC development processes.

Explore innovative process and facility models that optimize efficiency, sustainability, and cost-effectiveness in biopharmaceutical manufacturing.

We partnered with Spokane Community College to launch a biomanufacturing program, building career pathways and community talent for their growing life sciences and pharma manufacturing sector.

Dr. Peter O'Callaghan addresses questions surrounding GS piggyBac® transposase technology, from how it works, to why you should be using it in your development process for the expression of biologics.

Ensure fast, reliable, temperature-controlled logistics with a global infrastructure designed to protect critical biologic materials and keep development programs running smoothly and on schedule.

Pedro Morales, Director, Scientific Advisor of Biologics Analytical Services, explores how Catalent delivers tailored solutions through deep expertise and advanced capabilities.

Consider the benefits of the miFuc™ platform's compatibility with various host cell lines, how it works across multiple vector configurations, and reduces core fucose within any cell line.

Move drug development into the modern era with a contract research organization that offers assay development and validation, bioanalytical testing, sample prep, and more.

We offer end-to-end microbial services, including cell line development, process development, scale-up, and both clinical and commercial GMP manufacturing.

Integrated device assembly, labeling, and packaging solutions streamline pharma delivery, ensuring compliance, scalability, and patient-centric design from clinical trials to commercial production.

This presentation details how integrating robust chromatography with advanced TFF techniques enhances process efficiency and helps ensure consistent batch quality.

Accelerate vaccine development with integrated services, supporting all common vaccine types from discovery through IND. Leverage expertise in immunogenicity, dose-response, and efficacy studies.